GEN Exclusives

More »

GEN News Highlights

More »
Apr 7, 2008

Noxxon Receives $1.6M German Gov’t Grant to Accelerate Oligo Research

  • Noxxon was awarded a $1.6M (1M euro) research grant from Germany’s Federal Ministry of Education and Research. The funding was offered under the BioChancePlus initiative, a program that supports innovative research in biotechnology companies.

    The grant will be applied to strengthening and broadening the firm’s Spiegelmer® drug discovery platform to identify innovative medicines.

    A Spiegelmer® is a mirror-image oligonucleotide that can bind to a pharmacologically relevant target molecule in a manner conceptually similar to an antibody that recognizes an antigen, according to the company. The mirror image configuration of the oligonucleotide reportedly confers stability in all biological environments, as naturally occurring nucleases cannot degrade Spiegelmers.

     



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?